FibrobiologicsFBLG
13F holders, Q1 2024 (March 31)17holders
1famous investor
$10.78avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Fibrobiologics Inc. (FBLG) in their 13F filings. The largest holders were Millennium Management ($2.3M), HRT Financial LP ($619K) and Marshall Wace, LLP ($562K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Fibrobiologics Inc.
- CUSIP
- 31573L105
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $5.0M |
| Exits | 0 | $0 |
Ownership 17 holders
| Millennium Management | 0.00% | New | 209,231 | $2.3M |
| HRT Financial LP | 0.00% | New | 57,344 | $619K |
| Marshall Wace, LLP | 0.00% | New | 52,025 | $562K |
| Citigroup Inc. | 0.00% | New | 30,419 | $329K |
| ExodusPoint Capital Management, LP | 0.00% | New | 25,591 | $277K |
| JPMorgan Chase & Co. | 0.00% | New | 22,634 | $245K |
| NewEdge Advisors, LLC | 0.00% | New | 17,906 | $194K |
| Point72 (DIFC) Ltd | 0.01% | — | 15,915 | $172K |
| Balyasny Asset Management L.P. | 0.00% | New | 14,246 | $154K |
| BlackRock Inc. | 0.00% | New | 13,190 | $143K |
| Geode Capital Management, LLC | 0.00% | New | 10,989 | $119K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 8,978 | $97K |
| Royal Bank of Canada | 0.00% | New | 400 | $4K |
| Allworth Financial LP | 0.00% | New | 261 | $3K |
| Wells Fargo & Company | 0.00% | New | 200 | $2K |
| UBS Group AG | 0.00% | New | 28 | $303 |
| Macquarie Group Ltd. | 0.00% | New | 1,073 | $12 |
"% of holder's portfolio" is FBLG's weight in each manager's 13F, not the share of Fibrobiologics Inc. the manager owns.